Literature DB >> 8469855

Angiotensin II stimulates respiration in awake dogs and antagonizes baroreceptor inhibition.

P J Ohtake1, D B Jennings.   

Abstract

The effects of intravenous infusions of physiologic doses of angiotensin II (AII) on expired ventilation (VE) and acid-base balance were determined in awake dogs. A control infusion of saline was followed by AII infusion, initially with mean arterial pressure (MAP) raised 15%, and then with MAP at control levels by concurrent infusion of sodium nitroprusside (SNP). To control for SNP, the protocol was repeated using arginine vasopressin (AVP). Ventilatory responses to CO2 (VRC) were measured at the end of these protocols and separately with MAP elevated during infusion of AII. With AVP, increased MAP inhibited VE, heart rate (HR) and metabolism. However, with MAP elevated during AII infusion, stimulation by AII opposed baroreceptor reflexes and these variables, as well as plasma AVP, did not change. When MAP was lowered to control during AII infusion all variables increased. With AII, PaCO2 followed VE changes, decreasing 3 Torr with MAP at control levels; however, [H+] remained constant due to a decrease in arterial strong ion difference. The stimulatory effects of AII were not due to SNP; SNP did not stimulate VE during AVP infusion. The slope of the VRC was unaltered by AII infusion or MAP; however, AVP reduced the VRC slope. Physiological increases in AII stimulate VE and other systems at normal MAP and maintain several regulatory systems at control levels during baroreceptor inhibition.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8469855     DOI: 10.1016/0034-5687(93)90110-v

Source DB:  PubMed          Journal:  Respir Physiol        ISSN: 0034-5687


  10 in total

1.  Changes in arterial blood pressure elicited by severe passive heating at rest is associated with hyperthermia-induced hyperventilation in humans.

Authors:  Naoto Fujii; Masashi Ichinose; Yasushi Honda; Bun Tsuji; Kazuhito Watanabe; Narihiko Kondo; Takeshi Nishiyasu
Journal:  Eur J Appl Physiol       Date:  2012-05-09       Impact factor: 3.078

2.  Hyperventilation during orthostatic challenge in spinal cord-injured humans.

Authors:  Hisayoshi Ogata; Miwa Nakahara; Takeshi Sato; Shinya Hoshikawa; Toru Ogata; Kimitaka Nakazawa
Journal:  Clin Auton Res       Date:  2009-08-12       Impact factor: 4.435

3.  Angiotensin II mobilizes intracellular calcium and activates pannexin-1 channels in rat carotid body type II cells via AT1 receptors.

Authors:  Sindhubarathi Murali; Min Zhang; Colin A Nurse
Journal:  J Physiol       Date:  2014-08-28       Impact factor: 5.182

Review 4.  Chemoreflex function in heart failure.

Authors:  H D Schultz; S Y Sun
Journal:  Heart Fail Rev       Date:  2000-03       Impact factor: 4.214

5.  Angiotensin AT1 receptor-mediated excitation of rat carotid body chemoreceptor afferent activity.

Authors:  A M Allen
Journal:  J Physiol       Date:  1998-08-01       Impact factor: 5.182

6.  Commentary: Central-acting therapeutics alleviate respiratory weakness caused by heart failure-induced ventilatory overdrive.

Authors:  Amy M Pastva; Julia K L Walker
Journal:  Front Physiol       Date:  2018-05-23       Impact factor: 4.566

7.  Brain neuropeptides in central ventilatory and cardiovascular regulation in trout.

Authors:  Jean-Claude Le Mével; Frédéric Lancien; Nagi Mimassi; J Michael Conlon
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-30       Impact factor: 5.555

8.  Carotid Body AT(4) Receptor Expression and its Upregulation in Chronic Hypoxia.

Authors:  Man-Lung Fung; Siu-Yin Lam; Tung-Po Wong; Yung-Wui Tjong; Po-Sing Leung
Journal:  Open Cardiovasc Med J       Date:  2007-06-11

Review 9.  The role of local renin-angiotensin system in arterial chemoreceptors in sleep-breathing disorders.

Authors:  Man Lung Fung
Journal:  Front Physiol       Date:  2014-09-05       Impact factor: 4.566

10.  Glial Cells Are Involved in ANG-II-Induced Vasopressin Release and Sodium Intake in Awake Rats.

Authors:  Atalia F L Flôr; José L de Brito Alves; Maria S França-Silva; Camille M Balarini; Lucila L K Elias; Silvia G Ruginsk; José Antunes-Rodrigues; Valdir A Braga; Josiane C Cruz
Journal:  Front Physiol       Date:  2018-05-01       Impact factor: 4.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.